Novel urea oligomers, the preparation method thereof and pharmaceutical composition containing same
    11.
    发明申请
    Novel urea oligomers, the preparation method thereof and pharmaceutical composition containing same 有权
    新型尿素低聚物,其制备方法和含有其的药物组合物

    公开(公告)号:US20050038105A1

    公开(公告)日:2005-02-17

    申请号:US10491549

    申请日:2002-10-02

    摘要: Compounds having a general formula X-(A)n-Y, wherein: n varies between 6 and 20; X denotes a hydrogen atom, an RaCO, RaOCO, RaNHCO or RaSO2 group, Ra being an alkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl group, the groups being substituted or not, on condition that X is different from H when n is equal to 6; A denotes either a group having formula (I) or (II), wherein Ri is a hydrogen atom, an amino acid side chain, an alkyl, alkenyl, alkynyl, aryl, aralkyl or heteroaryl group, said groups being substituted or not, i being an integer of between 1 and n; Y is an NRbRc, Rb and Rc group having the same meaning as given earlier for Ra. The compounds are used for the preparation of medicaments that are intended to treat bacterial, fungal or cytotoxic diseases and, in particular, fungal infections, such as aspergillosis and candidiasis, and resistant bacterial infections.

    摘要翻译: 具有通式X-(A)n-Y的化合物,其中:n在6和20之间变化; X表示氢原子,RaCO,RaOCO,RaNHCO或RaSO2基团,Ra是烷基,烯基,炔基,芳基,芳烷基,杂芳基,该基团被取代或未被取代,条件是当n为 等于6; A表示具有式(I)或(II)的基团,其中R 1是氢原子,氨基酸侧链,烷基,烯基,炔基,芳基,芳烷基或杂芳基,所述基团被取代, 是1和n之间的整数; Y是具有与先前对Ra相同的含义的NRbRc,Rb和Rc基团。 这些化合物用于制备用于治疗细菌,真菌或细胞毒性疾病,特别是真菌感染如曲霉病和念珠菌病以及抗性细菌感染的药物。

    Urea oligomers, the preparation method thereof and pharmaceutical composition containing same
    14.
    发明授权
    Urea oligomers, the preparation method thereof and pharmaceutical composition containing same 有权
    尿素低聚物,其制备方法和含有它的药物组合物

    公开(公告)号:US07691899B2

    公开(公告)日:2010-04-06

    申请号:US10491549

    申请日:2002-10-02

    IPC分类号: A01N43/16 A01N43/10 A01N37/18

    摘要: Compounds having a general formula X-(A)n-Y, wherein: n varies between 6 and 20; X denotes a hydrogen atom, an RaCO, RaOCO, RaNHCO or RaSO2 group, Ra being an alkyl, alkenyl, alkynyl, aryl, aralkyl, heteroaryl group, the groups being substituted or not, on condition that X is different from H when n is equal to 6; A denotes either a group having formula (I) or (II), wherein Ri is a hydrogen atom, an amino acid side chain, an alkyl, alkenyl, alkynyl, aryl, aralkyl or heteroaryl group, said groups being substituted or not, i being an integer of between 1 and n; Y is an NRbRc, Rb and Rc group having the same meaning as given earlier for Ra. The compounds are used for the preparation of medicaments that are intended to treat bacterial, fungal or cytotoxic diseases and, in particular, fungal infections, such as aspergillosis and candidiasis, and resistant bacterial infections.

    摘要翻译: 具有通式X-(A)n-Y的化合物,其中:n在6和20之间变化; X表示氢原子,RaCO,RaOCO,RaNHCO或RaSO2基团,Ra是烷基,烯基,炔基,芳基,芳烷基,杂芳基,该基团被取代或未被取代,条件是当n为 等于6; A表示具有式(I)或(II)的基团,其中R 1是氢原子,氨基酸侧链,烷基,烯基,炔基,芳基,芳烷基或杂芳基,所述基团被取代, 是1和n之间的整数; Y是具有与先前对Ra相同的含义的NRbRc,Rb和Rc基团。 这些化合物用于制备用于治疗细菌,真菌或细胞毒性疾病,特别是真菌感染如曲霉病和念珠菌病以及抗性细菌感染的药物。